02.12.2024
Sopharma closes the first stage of the acquisition of 68 marketing authorizations (NEUTRAL)
Read more
News
Filters
Filters
02.12.2024
Sopharma closes the first stage of the acquisition of 68 marketing authorizations (NEUTRAL)
02.12.2024
Sopharma’s Q3’24 consolidated net income surged 30.2% YoY, 30% above our estimate (POSITIVE)
02.12.2024
Doverie Q3’24 consolidated EPS down 1.4% YoY to BGN 0.84, however beating our expectations (NEUTRAL)
02.12.2024
Producer prices down by 1.4% MoM in Oct‘24